BRITISH SOCIETY FOR GENE AND CELL THERAPY

Registered charity 1114715 · accounts filings on the Charity Commission register · also known as BRITISH SOCIETY FOR GENE THERAPY, BSGT

The British Society for Gene and Cell Therapy aims to accelerate scientific progress and promote the public understanding of gene- and cell-therapies. BSGT holds an annual Public Open Day alongside the scientific conference and supports international exchanges and collaborations that aim to advance knowledge of the field.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income

£128k

Latest spending

£158k

Registered

2006

Accounts read

FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a deficit of £29,473 for the year ended 31 May 2025, compared to a surplus in the prior year. Total funds carried forward were £187,502, comprising £158,029 in unrestricted funds and a restricted fund deficit of £235,871. The directors confirmed the charity remains in a strong financial position and satisfied the exemption criteria for audit.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Public profiles (found on the charity’s own website): facebook

Trustees · trustee networks

Professor Stuart Anthony Nicklinchair
Dr Gerry McLachlan
Professor Rajvindra Karda

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year end	Income	Spending
31/05/2025	£128k	£158k
31/05/2024	£61k	£44k
31/05/2023	£166k	£33k
31/05/2022	£5k	£18k
31/05/2021	£4k	£16k

Common questions

Is BRITISH SOCIETY FOR GENE AND CELL THERAPY financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a deficit of £29,473 for the year ended 31 May 2025, compared to a surplus in the prior year. Total funds carried forward were £187,502, comprising £158,029 in unrestricted funds and a restricted fund deficit of £235,871. The directors confirmed the charity remains in a strong financial position and satisfied the exemption criteria for audit. Its FY2025 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Funder	Similar charities funded	Amount to them
THE COMPANY OF BIOLOGISTS	1	£140k
G M MORRISON CHARITABLE TRUST	1	£1k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with BRITISH SOCIETY FOR CELL BIOLOGY.

BRITISH SOCIETY FOR CELL BIOLOGY income £126k
THE BRITISH GERIATRICS SOCIETY income £1.8m
BRITISH SOCIETY FOR IMMUNOLOGY income £1.8m
THE GENETICS SOCIETY income £530k
THE BRITISH SOCIETY FOR HAEMATOLOGY income £3.3m
THE BRITISH TRANSPLANTATION SOCIETY income £774k

Side by side with its peers

Charity	Income	Top pay band	Staff >£60k	Reserves vs policy	Fundraising cost	Going concern
BRITISH SOCIETY FOR GENE AND CELL THERAPY	£128k	—	0	unclear	—	no doubt
BRITISH SOCIETY FOR CELL BIOLOGY FY2024	£126k	—	0	unclear	—	no doubt
THE BRITISH GERIATRICS SOCIETY FY2025	£1.8m	£110,001 - £120,000	—	unclear	—	no doubt
BRITISH SOCIETY FOR IMMUNOLOGY FY2025	£1.8m	—	4	above	—	no doubt
THE GENETICS SOCIETY FY2024	£530k	—	0	above	—	no doubt
THE BRITISH SOCIETY FOR HAEMATOLOGY FY2025	£3.3m	£80,001 - £90,000	1	above	0.0%	no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.